A PHASE 1B/2 UMBRELLA STUDY OF ANTI-PD-1 SASANLIMAB IN COMBINATION WITH OTHER THERAPIES FOR PATIENTS WITH STAGE IIIB/IV NON-SMALL CELL LUNG CANCER (NSCLC): THE LANDSCAPE 1011 TRIAL IN PROGRESS Meeting Abstract

Open Access Industry Collaboration International Collaboration

cited authors

  • Boyer, Michael; Patel, Sandip; Marron, Thomas; Pavlakis, Nick; Parakh, Sagun; Gadgeel, Shirish; Shafique, Michael; Hoyer, Robert; Camidge, D. Ross; Farber, Charles; Mehra, Ranee; Mekhail, Tarek; Blinman, Prunella; Kowalski, Karey; Davis, Craig; Pavlov, Dmitri; Gad, Nayra; Massarelli, Erminia

authors

Publication Date

  • November 1, 2021

webpage

published in

category

start page

  • A484

end page

  • A484

volume

  • 9